Form 4: Illumina Director Scott B. Ullem Acquires Shares in Lieu of Cash Compensation

Director Scott B. Ullem acquired 183 shares of Illumina stock on September 30, 2024, as part of an election to receive board and committee cash retainer fees in company stock.

Summary

• On September 30, 2024, Scott B. Ullem, a director of Illumina, Inc., acquired 183 shares of common stock.
• The acquisition was made in lieu of cash compensation for board and committee retainer fees.
• The price per share was $122.7793.
• Following the transaction, Ullem directly owns 4,733 shares of Illumina common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director taking stock in lieu of cash suggests confidence, but it's a routine transaction.

Positives

• A director electing to receive compensation in company stock can be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

Directors receiving stock in lieu of cash is a fairly common practice, especially in the biotech industry, as it aligns their interests with those of shareholders.

Comparison to Industry Standards

• Comparing this to other biotech companies, director compensation packages often include a mix of cash and stock options.
• For example, directors at companies like Regeneron and Amgen also receive stock as part of their compensation.
• The specific amount and structure vary based on company size, performance, and industry norms.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.

Key Dates